342 related articles for article (PubMed ID: 31874109)
1. HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING.
Luo X; Donnelly CR; Gong W; Heath BR; Hao Y; Donnelly LA; Moghbeli T; Tan YS; Lin X; Bellile E; Kansy BA; Carey TE; Brenner JC; Cheng L; Polverini PJ; Morgan MA; Wen H; Prince ME; Ferris RL; Xie Y; Young S; Wolf GT; Chen Q; Lei YL
J Clin Invest; 2020 Apr; 130(4):1635-1652. PubMed ID: 31874109
[TBL] [Abstract][Full Text] [Related]
2. cGAS-STING responses are dampened in high-risk HPV type 16 positive head and neck squamous cell carcinoma cells.
Shaikh MH; Bortnik V; McMillan NA; Idris A
Microb Pathog; 2019 Jul; 132():162-165. PubMed ID: 31054871
[TBL] [Abstract][Full Text] [Related]
3. Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine.
Tan YS; Sansanaphongpricha K; Xie Y; Donnelly CR; Luo X; Heath BR; Zhao X; Bellile E; Hu H; Chen H; Polverini PJ; Chen Q; Young S; Carey TE; Nör JE; Ferris RL; Wolf GT; Sun D; Lei YL
Clin Cancer Res; 2018 Sep; 24(17):4242-4255. PubMed ID: 29769207
[No Abstract] [Full Text] [Related]
4. Human Papilloma Virus Specific Immunogenicity and Dysfunction of CD8
Krishna S; Ulrich P; Wilson E; Parikh F; Narang P; Yang S; Read AK; Kim-Schulze S; Park JG; Posner M; Wilson Sayres MA; Sikora A; Anderson KS
Cancer Res; 2018 Nov; 78(21):6159-6170. PubMed ID: 30154146
[TBL] [Abstract][Full Text] [Related]
5. Loss of HPV type 16 E7 restores cGAS-STING responses in human papilloma virus-positive oropharyngeal squamous cell carcinomas cells.
Bortnik V; Wu M; Julcher B; Salinas A; Nikolic I; Simpson KJ; McMillan NA; Idris A
J Microbiol Immunol Infect; 2021 Aug; 54(4):733-739. PubMed ID: 32768338
[TBL] [Abstract][Full Text] [Related]
6. An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma.
Carper MB; Troutman S; Wagner BL; Byrd KM; Selitsky SR; Parag-Sharma K; Henry EC; Li W; Parker JS; Montgomery SA; Cleveland JL; Williams SE; Kissil JL; Hayes DN; Amelio AL
Cell Rep; 2019 Nov; 29(6):1660-1674.e7. PubMed ID: 31693903
[TBL] [Abstract][Full Text] [Related]
7. CD8
Masterson L; Lechner M; Loewenbein S; Mohammed H; Davies-Husband C; Fenton T; Sudhoff H; Jani P; Goon P; Sterling J
Eur J Cancer; 2016 Nov; 67():141-151. PubMed ID: 27669501
[TBL] [Abstract][Full Text] [Related]
8. STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPV
Lu S; Concha-Benavente F; Shayan G; Srivastava RM; Gibson SP; Wang L; Gooding WE; Ferris RL
Oral Oncol; 2018 Mar; 78():186-193. PubMed ID: 29496049
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line.
Harris M; Wang XG; Jiang Z; Goldberg GL; Casadevall A; Dadachova E
Head Neck Oncol; 2011 Feb; 3(1):9. PubMed ID: 21314983
[TBL] [Abstract][Full Text] [Related]
10. Identification of High-Risk Human Papillomavirus DNA, p16, and E6/E7 Oncoproteins in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.
Lifsics A; Groma V; Cistjakovs M; Skuja S; Deksnis R; Murovska M
Viruses; 2021 May; 13(6):. PubMed ID: 34072187
[TBL] [Abstract][Full Text] [Related]
11. Activating STING/TBK1 suppresses tumor growth via degrading HPV16/18 E7 oncoproteins in cervical cancer.
Huang X; Huo L; Xiao B; Ouyang Y; Chen F; Li J; Zheng X; Wei D; Wu Y; Zhang R; Cao X; Kang T; Gao Y
Cell Death Differ; 2024 Jan; 31(1):78-89. PubMed ID: 38007552
[TBL] [Abstract][Full Text] [Related]
12. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
[TBL] [Abstract][Full Text] [Related]
13. HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes.
Chatfield-Reed K; Gui S; O'Neill WQ; Teknos TN; Pan Q
Oral Oncol; 2020 Jan; 100():104488. PubMed ID: 31835137
[TBL] [Abstract][Full Text] [Related]
14. Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer.
Heusinkveld M; Goedemans R; Briet RJ; Gelderblom H; Nortier JW; Gorter A; Smit VT; Langeveld AP; Jansen JC; van der Burg SH
Int J Cancer; 2012 Jul; 131(2):E74-85. PubMed ID: 22020783
[TBL] [Abstract][Full Text] [Related]
15. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.
Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z
Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976
[TBL] [Abstract][Full Text] [Related]
16. Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest.
Li C; Johnson DE
Cell Cycle; 2013 Mar; 12(6):923-34. PubMed ID: 23421999
[TBL] [Abstract][Full Text] [Related]
17. Estrogen Attenuates the Growth of Human Papillomavirus-Positive Epithelial Cells.
Bristol ML; James CD; Wang X; Fontan CT; Morgan IM
mSphere; 2020 Mar; 5(2):. PubMed ID: 32188745
[TBL] [Abstract][Full Text] [Related]
18. A novel function of HPV16-E6/E7 in epithelial-mesenchymal transition.
Jung YS; Kato I; Kim HR
Biochem Biophys Res Commun; 2013 Jun; 435(3):339-44. PubMed ID: 23628416
[TBL] [Abstract][Full Text] [Related]
19. Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells.
Kahue CN; Jerrell RJ; Parekh A
Cancer Rep (Hoboken); 2018 Oct; 1(3):e1125. PubMed ID: 32721084
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
